{"id":"W3139210094","doi":"10.1016/s2665-9913(21)00010-2","title":"Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study","year":2021,"lang":"en","type":"article","venue":"The Lancet Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Pfizer (Canada); Toronto Western Hospital","funders":"National Institute for Health and Care Research; Catholic Medical Center; Pfizer","keywords":"Tofacitinib; Medicine; Psoriatic arthritis; Tolerability; Adverse effect; Placebo; Janus kinase inhibitor; Internal medicine; Methotrexate; Psoriasis; Incidence (geometry); Arthritis; Surgery; Rheumatoid arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003587013,0.00106834,0.00259337,0.0005450298,0.0005355237,0.001383748,0.0006140756,0.001099685,0.001993758],"category_scores_gemma":[0.003178654,0.0004144366,0.003891195,0.0007107903,0.0005388311,0.001272931,0.0005186464,0.002030343,0.0004238361],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007055023,"about_ca_system_score_gemma":0.0007311615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001394854,"about_ca_topic_score_gemma":0.002765587,"domain_scores_codex":[0.9988413,0.0004538057,0.0001117289,0.000206144,0.0001925588,0.0001944637],"domain_scores_gemma":[0.997535,0.0006903645,0.0008667331,0.0002462282,0.0002304126,0.0004312224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8113835,0.001958177,0.09382562,0.001684652,0.01663302,0.0002363068,0.0001941161,0.001455845,0.003695589,0.0001582322,0.001810836,0.06696416],"study_design_scores_gemma":[0.2719404,0.08516846,0.6025506,0.0004862046,0.0299476,0.0007073176,0.0002649791,0.001574625,0.001398064,0.0007953397,0.00500703,0.0001594314],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741542,0.02089138,0.0002363124,0.0003351578,0.0001245927,0.0001544476,0.002329827,0.00002979056,0.001744395],"genre_scores_gemma":[0.9933448,0.002894244,0.0001787337,0.0003209517,0.0001883182,0.0001081136,0.002296032,0.0000090071,0.0006597738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003587013,"threshold_uncertainty_score":0.01897013,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01622354310530569,"score_gpt":0.2781429838210079,"score_spread":0.2619194407157023,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}